Navigation Links
New Federal Stem Cell Rules Would Hinder Existing Research, Consumer Group Warns
Date:5/20/2009

NIH Should Fix Standards to Allow Use of Current Stem Cell Lines

SANTA MONICA, Calif., May 20 /PRNewswire-USNewswire/ -- -- Regulations governing stem cell research proposed by the Obama Administration -- unless modified before final implementation on July 1 -- prohibit federal funding of important research that had received funding under the Bush Administration, Consumer Watchdog said today. The nonpartisan, nonprofit group called on the National Institutes of Health to change the draft regulations.

On March 9, President Obama signed an executive order intended to lift restrictions on federal funding of human embryonic stem cell research. As part of the order, the National Institutes of Health (NIH) were directed to develop regulations "to help ensure that NIH-funded research in this area is ethically responsible, scientifically worthy, and conducted in accordance with applicable law."

"Most of us were heartened when President Obama lifted Bush Administration restrictions on funding stem cell research, but the perverse effect of these proposed NIH rules is that the limited research scientists were able to conduct under Bush will now be ineligible for federal funding," said John M. Simpson, Consumer Watchdog's Stem Cell Project Director. "Certainly this is not what President Obama intended and the regulations must be modified."

Bush allowed the NIH to fund research on embryonic stem cell lines that were derived before 9 pm, Aug. 9, 2001. In practice there were about 20 lines that were available to scientists that qualified for federal money. Embryonic stem cells, which have the potential to develop into virtually any cell in the body, are derived from embryos left over from in vitro fertilization (IVF) treatments and would otherwise be destroyed.

The Bush approved stem cell lines were derived before the proposed NIH rules and do not meet some of their specific technical standards. In addition some stem cell lines derived with state or private funding or in other countries since 2001 don't meet some of the technical specifications of the proposed NIH rules.

For instance, under the new NIH guidelines donors would have to be told that the embryos would be used for stem cell research. When some of the earlier lines were derived, donors were told more generically that the embryos would be used for research. The new regulations call for an explicit statement that the results of using the human embryonic stem cells may have commercial potential and that the donor would not receive any financial benefit from such commercial development. They also would have to be told that the stem cell lines derived from the donated embryos might be maintained for many years.

"The NIH guidelines set the highest standards and make sense going forward," said Simpson. "However the earlier lines were derived under Institutional Review Board (IRB) supervision, following ethical guidelines then in place, suggested by such organizations as the National Academies of Science, or covered by state regulations like those of the California Institute of Regenerative Medicine. It would be wrong to preclude them from federal funding going forward. You can't hold someone to standards that didn't exist when these lines were derived in good faith according to then existing standards."

Consumer Watchdog supports modifications proposed by the California Institute for Regenerative Medicine (CIRM) and suggestions raised by the Interstate Alliance on Stem Cell Research.

The draft NIH regulations are open for public comment until May 26. Comments may be made on line here: http://nihoerextra.nih.gov/stem_cells/add.htm .

Read the proposed regulations here: http://edocket.access.gpo.gov/2009/E9-9313.htm

Read CIRM's comments here: http://www.cirm.ca.gov/sites/default/files/NIH%20Comments%20NIH_guidelines%20v12_5_14.pdf

Read the Interstate Alliance on Stem Cell Research discussion of the regulations here: http://www.iascr.org/docs/May2009/IASCR_Summary_NIH_Discussion.pdf

Consumer Watchdog, formerly the Foundation for Taxpayer and Consumer Rights is a nonprofit, nonpartisan organization with offices in Washington, DC and Santa Monica, Ca. Our website is www.consumerwatchdog.org .


'/>"/>
SOURCE Consumer Watchdog
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. State, Federal Officials Remind Health Care Workers, Other at-Risk Individuals to Get Annual Flu Shot
2. Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates
3. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
4. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
5. A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe
6. A Drug With Efficacy Superior to That of Xenical at Inducing Weight Loss Would Earn a 40 Percent Patient Share in the Obesity Drug Market
7. Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
8. Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib)
9. CoAxia(TM) Announces $11.5M Equity Financing From Existing Investors
10. Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases
11. Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... 23, 2016 Global Paclitaxel Market ... profiles 12 companies and the Paclitaxel analysis in this ... the industry and its players. This is ... nature, details the current state of the industry while ... classifications, applications and industry chain structure. The Paclitaxel market ...
(Date:5/23/2016)... ALBANY, New York , May 23, 2016 /PRNewswire/ ... new market report titled, " Exocrine Pancreatic Insufficiency Market ... Forecast 2013 - 2023 ." According to the report, ... at a CAGR of 8.3% from 2015 to 2023 ... pancreatic insufficiency (EPI) is a condition characterized by the ...
(Date:5/23/2016)... Clarifying Vision - Prospects and Developments in ... What can be expected from the Ophthalmic ... the fastest rates? This visiongain report shows ... and prospects. ,Our 190-page report provides ... areas in the industry and the future market prospects. ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... ... Sterling Global Products is launching a Kickstarter campaign focused on “PAW Patrol ... campaign kick-off video is located via this link https://youtu.be/WsO4qz2odco . The campaign will ... raise $1,000 per day for a total of $25,000. The funds will be used ...
(Date:5/24/2016)... , ... May 24, 2016 , ... ... of its services to provide one resource, from start to finish, for Life ... Life Safety Statement of Condition surveys requested by the Joint Commission, and fire ...
(Date:5/24/2016)... , ... May 24, 2016 , ... ... organization, is pleased to welcome new Partner Firm Austin & Co., Inc. ... approach to insurance, employee benefits, HR consulting, benefits technology, and beyond. As ...
(Date:5/24/2016)... ... May 24, 2016 , ... How to Write Error Free Procedures, ... http://www.fdanews.com/humanerrordrugdevice , Human error is known to be the major cause of quality ... ever be totally eliminated, many human performance problems can be prevented. , How to ...
(Date:5/24/2016)... ... (PRWEB) May 24, 2016 -- Grow Healthy ... Advisory Board. Joining the Grow Healthy Advisory Board team are ... embody the mission of our organization and bring talent, expertise and ... as we continue to expand our footprint as the leader in ...
Breaking Medicine News(10 mins):